Related Experiment Video
Updated: May 20, 2025

Author Spotlight: Shear Assay Protocol for the Determination of Single-Cell Material Properties
Published on: May 19, 2023
In vivo targeted and deterministic single-cell malignant transformation
Pierluigi Scerbo1,2, Benjamin Tisserand1, Marine Delagrange1,3
1Laboratoire de Physique de l'Ecole Normale Supérieure LPENS, ENS, PSL Research University, CNRS, Sorbonne Université, Université de Paris, Paris, France.
Abstract:
Why does a normal cell possibly harboring genetic mutations in oncogene or tumor suppressor genes becomes malignant and develops a tumor is a subject of intense debate. Various theories have been proposed but their experimental test has been hampered by the unpredictable and improbable malignant transformation of single cells. Here, using an optogenetic approach we permanently turn on an oncogene (KRASG12V) in a single cell of a zebrafish brain that, only in synergy with the transient co-activation of a reprogramming factor (VENTX/NANOG/OCT4), undergoes a deterministic malignant transition and robustly and reproducibly develops within 6 days into a full-blown tumor. The controlled way in which a single cell can thus be manipulated to give rise to cancer lends support to the 'ground state theory of cancer initiation' through 'short-range dispersal' of the first malignant cells preceding tumor growth.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
In-vitro Mutagenesis

